|
TMEM194B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.83779658158301E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.06639960487598E-10 |
| Normal-vs-Stage2 |
4.045400E-04 |
| Normal-vs-Stage3 |
3.80369957753146E-10 |
| Normal-vs-Stage4 |
1.60100044332978E-10 |
| Stage1-vs-Stage2 |
3.349800E-01 |
| Stage1-vs-Stage3 |
6.394000E-02 |
| Stage1-vs-Stage4 |
1.238490E-02 |
| Stage2-vs-Stage3 |
5.294500E-02 |
| Stage2-vs-Stage4 |
1.267940E-02 |
| Stage3-vs-Stage4 |
3.650800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.57571741713036E-13 |
| Normal-vs-AfricanAmerican |
4.444800E-04 |
| Normal-vs-Asian |
3.033200E-04 |
| Caucasian-vs-AfricanAmerican |
2.383600E-01 |
| Caucasian-vs-Asian |
1.173800E-02 |
| AfricanAmerican-vs-Asian |
5.061800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.07830033369805E-10 |
| Normal-vs-Female |
9.38680244644274E-11 |
| Male-vs-Female |
3.512800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.24629997620008E-09 |
| Normal-vs-Age(41-60Yrs) |
9.60059809429481E-11 |
| Normal-vs-Age(61-80Yrs) |
3.05939995559612E-09 |
| Normal-vs-Age(81-100Yrs) |
5.960000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.645600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.718400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.317400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.632000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.913200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.426800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.825900E-04 |
| Classical-VS-Follicular |
6.031800E-01 |
| Classical-VS-Other |
2.889600E-01 |
| Classical-VS-Normal |
1.52640011741312E-10 |
| Tall-VS-Follicular |
4.960600E-03 |
| Tall-VS-Other |
5.520800E-01 |
| Tall-VS-Normal |
6.53709975040329E-10 |
| Follicular-VS-Other |
3.093800E-01 |
| Follicular-VS-Normal |
1.8490300000007E-05 |
| Other-VS-Normal |
1.116930E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0128999861081E-09 |
| Normal-vs-N1 |
5.84260417824112E-11 |
| N0-vs-N1 |
3.762200E-02 |
|
|
